EP1140851A1 — 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
Assigned to Pharmacia and Upjohn Co LLC · Expires 2001-10-10 · 25y expired
What this patent protects
The present invention provides a compound of formula (I) Wherein R1 is C¿1-7? alkyl, optionally substituted by hydroxy or NR?4R5; R2¿ is C¿1-7? alkyl substituted by hydroxy or NR?4R5; R3¿ is H, F or C¿1-7? alkoxy; R?4 and R5¿ together with N are a 5- or 6-membered heterocyclic mo…
USPTO Abstract
The present invention provides a compound of formula (I) Wherein R1 is C¿1-7? alkyl, optionally substituted by hydroxy or NR?4R5; R2¿ is C¿1-7? alkyl substituted by hydroxy or NR?4R5; R3¿ is H, F or C¿1-7? alkoxy; R?4 and R5¿ together with N are a 5- or 6-membered heterocyclic moiety having 1-3 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur in which sulfur may be substituted by one (1) or two (2) oxygen atoms; and pharmaceutically acceptable salts thereof. Compounds of formula (I) of the present invention are useful as antiviral agents.
Drugs covered by this patent
- Tybost (COBICISTAT) · Gilead Sciences
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.